Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02002806 · ClinicalTrials.gov registry record · NA

Surgery Plus Celiac Nerve Block for Long-term Pancreatic Cancer Pain Control

A NA study, sponsored by Indiana University.

Completed
Registry status
NA
Development phase
150
Enrollment target

NCT02002806 is a NA study that has completed, run by Indiana University. The registered enrollment target is 150 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02002806, a NA study, has completed, sponsored by Indiana University.

COMPLETED
Registry status
NA
Development phase
150 participants
Enrollment target

Study Summary

This is a randomized study of surgery plus chemical nerve block versus surgery plus placebo for pain control in subjects with pancreatic cancer.

Interventions

  • OTHER Placebo Injection
  • OTHER Alcohol Injection

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2012-01
Est. Completion 2019-06
Phase NA

Sponsor

Indiana University

890 total trials

What the Registry Record Tells You About NCT02002806

The ClinicalTrials.gov registry entry for NCT02002806 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Placebo Injection is the first listed.

NCT02002806 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02002806 about?

NCT02002806 is a clinical study titled "Surgery Plus Celiac Nerve Block for Long-term Pancreatic Cancer Pain Control". This is a randomized study of surgery plus chemical nerve block versus surgery plus placebo for pain control in subjects with pancreatic cancer.

What is the current status of trial NCT02002806?

This trial is currently completed. It is a NA study. The enrollment target is 150 participants. The study started on 2012-01. Estimated completion is 2019-06.

What interventions are being tested in trial NCT02002806?

The interventions under investigation include: Placebo Injection (OTHER), Alcohol Injection (OTHER).

Who is sponsoring clinical trial NCT02002806?

This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.